{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T01:10:54Z","timestamp":1768525854429,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T00:00:00Z","timestamp":1474934400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00428-016-2025-7","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T12:14:00Z","timestamp":1474978440000},"page":"5-20","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":90,"title":["Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL"],"prefix":"10.1007","volume":"470","author":[{"name":"On behalf of IQN Path ASBL","sequence":"first","affiliation":[]},{"given":"Zandra C","family":"Deans","sequence":"first","affiliation":[]},{"given":"Jose Luis","family":"Costa","sequence":"additional","affiliation":[]},{"given":"Ian","family":"Cree","sequence":"additional","affiliation":[]},{"given":"Els","family":"Dequeker","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Edsj\u00f6","sequence":"additional","affiliation":[]},{"given":"Shirley","family":"Henderson","sequence":"additional","affiliation":[]},{"given":"Michael","family":"Hummel","sequence":"additional","affiliation":[]},{"given":"Marjolijn JL","family":"Ligtenberg","sequence":"additional","affiliation":[]},{"given":"Marco","family":"Loddo","sequence":"additional","affiliation":[]},{"given":"Jose Carlos","family":"Machado","sequence":"additional","affiliation":[]},{"given":"Antonio","family":"Marchetti","sequence":"additional","affiliation":[]},{"given":"Katherine","family":"Marquis","sequence":"additional","affiliation":[]},{"given":"Joanne","family":"Mason","sequence":"additional","affiliation":[]},{"given":"Nicola","family":"Normanno","sequence":"additional","affiliation":[]},{"given":"Etienne","family":"Rouleau","sequence":"additional","affiliation":[]},{"given":"Ed","family":"Schuuring","sequence":"additional","affiliation":[]},{"given":"Keeda-Marie","family":"Snelson","sequence":"additional","affiliation":[]},{"given":"Erik","family":"Thunnissen","sequence":"additional","affiliation":[]},{"given":"Bastiaan","family":"Tops","sequence":"additional","affiliation":[]},{"given":"Gareth","family":"Williams","sequence":"additional","affiliation":[]},{"given":"Han","family":"van Krieken","sequence":"additional","affiliation":[]},{"given":"Jacqueline A","family":"Hall","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,9,27]]},"reference":[{"issue":"6","key":"2025_CR1","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/gcc.22352","volume":"55","author":"M Jesinghaus","year":"2016","unstructured":"Jesinghaus M, Pfarr N, Endris V, Kloor M, Volckmar AL, Brandt R, Herpel E, Muckenhuber A, Lasitschka F, Schirmacher P, Penzel R, Weichert W, Stenzinger A (2016) Genotyping of colorectal cancer for cancer precision medicine: results from the IPH Center for Molecular Pathology. Genes Chromosomes Cancer 55(6):505\u2013521. doi: 10.1002\/gcc.22352","journal-title":"Genes Chromosomes Cancer"},{"issue":"12","key":"2025_CR2","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1093\/annonc\/mdu478","volume":"25","author":"FE Andre","year":"2014","unstructured":"Andre FE, Mardis SM, Soria JC, Siu LL, Swanton C (2014) Prioritizing targets for precision cancer medicine. Ann Oncol 25(12):2295\u20132303. doi: 10.1093\/annonc\/mdu478","journal-title":"Ann Oncol"},{"issue":"13","key":"2025_CR3","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/S1470-2045(15)00188-6","volume":"16","author":"C Le Tourneau","year":"2015","unstructured":"Le Tourneau C, Delord JP, Gon\u00e7alves A, Gavoille C, Dubot C, Isambert N, Campone M et al (2015) Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proof-of-concept, randomised, controlled phase 2 trial. Lancet Oncol 16(13):1324\u20131334. doi: 10.1016\/S1470-2045(15)00188-6","journal-title":"Lancet Oncol"},{"key":"2025_CR4","doi-asserted-by":"publisher","unstructured":"Tops BB, Normanno N, Kurth H, Amato E, Mafficini A, Rieber N, Le Corre D, Rachiglio AM, Reiman A, Sheils O, Noppen C, Lacroix L, Cree IA, Scarpa A, Ligtenberg MJ, Laurent-Puig P (2015) Development of a semi-conductor sequencing-based panel for genotyping of colon and lung cancer by the onconetwork consortium. BMC Cancer 15. doi: 10.1186\/s12885-015-1015-5","DOI":"10.1186\/s12885-015-1015-5"},{"issue":"2","key":"2025_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.jmoldx.2015.11.006","volume":"18","author":"KE Fisher","year":"2016","unstructured":"Fisher KE, Zhang L, Wang J, Smith GH, Newman S, Schneider TM, Pillai RN, Kudchadkar RR, Owonikoko TK, Ramalingam SS, Lawson DH, Delman KA, El-Rayes BF, Wilson MM, Sullivan HC, Morrison AS, Balci S, Adsay NV, Gal AA, Sica GL, Saxe DF, Mann KP, Hill CE, Khuri FR, Rossi MR (2016) Clinical validation and implementation of a targeted next-generation sequencing assay to detect somatic variants in non-small cell lung, melanoma, and gastrointestinal malignancies. J Mol Diagn 18(2):299\u2013315. doi: 10.1016\/j.jmoldx.2015.11.006","journal-title":"J Mol Diagn"},{"issue":"6","key":"2025_CR6","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nm.3559","volume":"20","author":"EM Van Allen","year":"2014","unstructured":"Van Allen EM, Wagle N, Stojanov P, Perrin DL, Cibulskis K, Marlow S, Jane-Valbuena J et al (2014) Whole-exome sequencing and clinical interpretation of formalin-fixed, paraffin-embedded tumor samples to guide precision cancer medicine. Nat Med 20(6):682\u2013688. doi: 10.1038\/nm.3559","journal-title":"Nat Med"},{"issue":"16","key":"2025_CR7","doi-asserted-by":"publisher","first-page":"30353","DOI":"10.1016\/j.lungcan.2016.05.024","volume":"S0169-5002","author":"B Doble","year":"2016","unstructured":"Doble B, John T, Thomas D, Fellowes A, Fox S, Lorgelly P (2016) Cost-effectiveness of precision medicine in the fourth-line treatment of metastatic lung adenocarcinoma: an early decision analytic model of multiplex targeted sequencing. Lung Cancer pii S0169-5002(16):30353\u201330351. doi: 10.1016\/j.lungcan.2016.05.024","journal-title":"Lung Cancer pii"},{"key":"2025_CR8","unstructured":"International Organization for Standardization (ISO). ISO\/IEC 17025:2005 General requirements for the competence of testing and calibration laboratories. https:\/\/www.iso.org\/obp\/ui\/#iso:std:iso-iec:17025:ed-2:v1:en (accessed July 21, 2016)."},{"key":"2025_CR9","unstructured":"International Organization for Standardization (ISO). ISO 15189:2012 Medical laboratories\u2014requirements for quality and competence. https:\/\/www.iso.org\/obp\/ui\/#iso:std:iso:15189:ed-3:v2:en (accessed July 21, 2016)."},{"key":"2025_CR10","unstructured":"https:\/\/www.amp.org\/committees\/clinical_practice\/AMPclinicalpracticeguidelines.cfm (accessed July 21, 2016)."},{"key":"2025_CR11","unstructured":"http:\/\/www.esmo.org\/Guidelines (accessed July 21, 2016)."},{"issue":"6","key":"2025_CR12","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1038\/nm.3854","volume":"21","author":"KS Thress","year":"2015","unstructured":"Thress KS, Paweletz CP, Felip E, Cho BC, Stetson D, Dougherty B, Lai Z, Markovets A, Vivancos A, Kuang Y, Ercan D, Matthews SE, Cantarini M, Barrett JC, J\u00e4nne PA, Oxnard GR (2015) Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790\u00a0M. Nat Med 21(6):560\u2013562. doi: 10.1038\/nm.3854 Epub 2015 May 4","journal-title":"Nat Med"},{"issue":"10","key":"2025_CR13","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1158\/1078-0432.CCR-14-2791","volume":"21","author":"R Katayama","year":"2015","unstructured":"Katayama R, Lovly CM, Shaw AT (2015) Therapeutic targeting of anaplastic lymphoma kinase in lung cancer: a paradigm for precision cancer medicine. Clin Cancer Res 21(10):2227\u20132235. doi: 10.1158\/1078-0432.CCR-14-2791","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2025_CR14","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nm.2609","volume":"18","author":"C Montagut","year":"2012","unstructured":"Montagut C, Dalmases A, Bellosillo B, Crespo M, Pairet S, Iglesias M, Salido M et al (2012) Identification of a mutation in the extracellular domain of the epidermal growth factor receptor conferring cetuximab resistance in colorectal cancer. Nat Med 18(2):221\u2013223. doi: 10.1038\/nm.2609","journal-title":"Nat Med"},{"issue":"3","key":"2025_CR15","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0002-9440(10)64266-6","volume":"161","author":"MP Tabor","year":"2002","unstructured":"Tabor MP, Brakenhoff RH, Ruijter-Schippers HJ, Van Der Wal JE, Snow GB, Leemans CR, Braakhuis BJ (2002) Multiple head and neck tumours frequently originate from a single preneoplastic lesion. Am J Pathol 161(3):1051\u20131060","journal-title":"Am J Pathol"},{"issue":"26","key":"2025_CR16","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR, O\u2019Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM, Prados MD, Wiemels J, Wiencke JK, Wrensch MR, Jenkins RB (2015) Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumours. N Engl J Med 372(26):2499\u20132508. doi: 10.1056\/NEJMoa1407279","journal-title":"N Engl J Med"},{"key":"2025_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ejhg.2015.226","volume":"24","author":"G Matthijs","year":"2016","unstructured":"Matthijs G, Souche E, Alders M, Corveleyn A, Eck S, Feenstra I, Race V, Sistermans E, Sturm M, Weiss M, Yntema H, Bakker E, Scheffer H, Bauer P (2016) Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet 24:2\u20135. doi: 10.1038\/ejhg.2015.226 published online 28 October 2015","journal-title":"Eur J Hum Genet"},{"key":"2025_CR18","unstructured":"Hall A, Hallowell N and Zimmern R (2013) Managing incidental and pertinent findings from WGS in the 100,000 Genomes Project. A discussion paper from the PHG Foundation. http:\/\/www.phgfoundation.org\/reports\/13799\/ (accessed July 21, 2016)"},{"issue":"7","key":"2025_CR19","doi-asserted-by":"publisher","first-page":"e69604","DOI":"10.1371\/journal.pone.0069604","volume":"8","author":"CM McCourt","year":"2013","unstructured":"McCourt CM, McArt DG, Mills K, Catherwood MA, Maxwell P, Waugh DJ, Hamilton P, O\u2019Sullivan JM, Salto-Tellez M (2013) Validation of next generation sequencing technologies in comparison to current diagnostic gold standards for BRAF, EGFR and KRAS mutational analysis. PLoS One 8(7):e69604. doi: 10.1371\/journal.pone.0069604","journal-title":"PLoS One"},{"key":"2025_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.5858\/arpa.2014-0250-CP","volume":"139","author":"N Aziz","year":"2015","unstructured":"Aziz N, Zhao Q, Bry L, Driscoll DK, Funke B, Gibson JS, Grody WW, Hegde MR, Hoeltge GA, Leonard DG, Merker JD, Nagarajan R, Palicki LA, Robetorye RS, Schrijver I, Weck KE, Voelkerding KV (2015) College of American Pathologists\u2019 laboratory standards for next-generation sequencing clinical tests. Arch Pathol Lab Med 139:481\u2013493. doi: 10.5858\/arpa.2014-0250-CP","journal-title":"Arch Pathol Lab Med"},{"issue":"11","key":"2025_CR21","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/nbt.2403","volume":"30","author":"AS Gargis","year":"2012","unstructured":"Gargis AS, Kalman L, Berry MW, Bick DP, Dimmock DP, Hambuch T, Lu F, Lyon E, Voelkerding KV, Zehnbauer BA, Agarwala R, Bennett SF, Chen B, Chin EL, Compton JG, Das S, Farkas DH, Ferber MJ, Funke BH, Furtado MR, Ganova-Raeva LM, Geigenm\u00fcller U, Gunselman SJ, Hegde MR, Johnson PL, Kasarskis A, Kulkarni S, Lenk T, Liu CS, Manion M, Manolio TA, Mardis ER, Merker JD, Rajeevan MS, Reese MG, Rehm HL, Simen BB, Yeakley JM, Zook JM, Lubin IM (2012) Assuring the quality of next-generation sequencing in clinical laboratory practice. Nat Biotechnol 30(11):1033\u20131036. doi: 10.1038\/nbt.2403","journal-title":"Nat Biotechnol"},{"issue":"4","key":"2025_CR22","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3390\/cancers7040874","volume":"7","author":"R Luthra","year":"2015","unstructured":"Luthra R, Chen H, Roy-Chowdhuri S, Singh RR (2015) Next-generation sequencing in clinical molecular diagnostics of cancer: advantages and challenges. Cancers (Basel) 7(4):2023\u20132036. doi: 10.3390\/cancers7040874","journal-title":"Cancers (Basel)"},{"key":"2025_CR23","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1136\/jclinpath-2014-202404","volume":"67","author":"IA Cree","year":"2014","unstructured":"Cree IA, Deans Z, Ligtenberg MJ et al (2014) Guidance for laboratories performing molecular pathology for cancer patients. J Clin Pathol 67:923\u2013931. doi: 10.1136\/jclinpath-2014-202404","journal-title":"J Clin Pathol"},{"key":"2025_CR24","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/gim.2013.92","volume":"15","author":"HL Rehm","year":"2013","unstructured":"Rehm HL, Bale SJ, Bayrak-Toydemir P, Berg JS, Brown KK, Deignan JL, Friez MJ, Funke BH, Hegde MR, Lyon E, Working Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Committee (2013) ACMG clinical laboratory standards for next-generation sequencing. Genet Med 15:733\u2013747. doi: 10.1038\/gim.2013.92","journal-title":"Genet Med"},{"key":"2025_CR25","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.jmoldx.2012.04.006","volume":"14","author":"I Schrijver","year":"2012","unstructured":"Schrijver I, Aziz N, Farkas DH, Furtado M, Gonzalez AF, Greiner TC, Grody WW, Hambuch T, Kalman L, Kant JA, Klein RD, Leonard DG, Lubin IM, Mao R, Nagan N, Pratt VM, Sobel ME, Voelkerding KV, Gibson JS (2012) Opportunities and challenges associated with clinical diagnostic genome sequencing: a report of the Association for Molecular Pathology. J Mol Diagn 14:525\u2013540. doi: 10.1016\/j.jmoldx.2012.04.006","journal-title":"J Mol Diagn"},{"key":"2025_CR26","unstructured":"Use of Public Human Genetic Variant Databases to Support Clinical Validity for Next Generation Sequencing (NGS)-Based In Vitro Diagnostics http:\/\/www.fda.gov\/downloads\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/UCM509837.pdf (accessed July 21, 2016)."},{"key":"2025_CR27","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3109\/10520295.2011.591832","volume":"87","author":"DG Hicks","year":"2012","unstructured":"Hicks DG, Boyce BF (2012) The challenge and importance of standardizing pre-analytical variables in surgical pathology specimens for clinical care and translational research. Biotech Histochem 87:14\u201317. doi: 10.3109\/10520295.2011.591832","journal-title":"Biotech Histochem"},{"key":"2025_CR28","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/labinvest.2011.75","volume":"91","author":"Y Bai","year":"2011","unstructured":"Bai Y, Tolles J, Cheng H et al (2011) Quantitative assessment shows loss of antigenic epitopes as a function of pre-analytic variables. Lab Investig 91:1253\u20131261. doi: 10.1038\/labinvest.2011.75","journal-title":"Lab Investig"},{"key":"2025_CR29","first-page":"4207","volume":"31","author":"P Bruno","year":"2011","unstructured":"Bruno P, Mariotta S, Ricci A et al (2011) Reliability of direct sequencing of EGFR: comparison between cytological and histological samples from the same patient. Anticancer Res 31:4207\u20134210","journal-title":"Anticancer Res"},{"key":"2025_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/cncy.21260","volume":"121","author":"PL Sun","year":"2013","unstructured":"Sun PL, Jin Y, Kim H, Lee CT, Jheon S, Chung JH (2013) High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas. Cancer Cytopathol 121:311\u2013319. doi: 10.1002\/cncy.21260","journal-title":"Cancer Cytopathol"},{"key":"2025_CR31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/cncy.21281","volume":"121","author":"NV Mitiushkina","year":"2013","unstructured":"Mitiushkina NV, Iyevleva AG, Poltoratskiy AN, Ivantsov AO, Togo AV, Polyakov IS, Orlov SV, Matsko DE, Novik VI, Imyanitov EN (2013) Detection of EGFR mutations and EML4-ALK rearrangements in lung adenocarcinomas using archived cytological slides. Cancer Cytopathol 121:370\u2013376","journal-title":"Cancer Cytopathol"},{"key":"2025_CR32","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1158\/1078-0432.CCR-12-1958","volume":"19","author":"F1 Buttitta","year":"2013","unstructured":"Buttitta F1, Felicioni L, Del Grammastro M, Filice G, Di Lorito A, Malatesta S, Viola P, Centi I, D\u2019Antuono T, Zappacosta R, Rosini S, Cuccurullo F, Marchetti A (2013) Effective assessment of EGFR mutation status in bronchoalveolar lavage and pleural fluids by next-generation sequencing. Clin Cancer Res 19:691\u2013698. doi: 10.1158\/1078-0432.CCR-12-1958","journal-title":"Clin Cancer Res"},{"issue":"2","key":"2025_CR33","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1136\/jclinpath-2014-202644","volume":"68","author":"JR Kapp","year":"2015","unstructured":"Kapp JR, Diss T, Spicer J, Gandy M, Schrijver I, Jennings LJ, Li MM, Tsongalis GJ, de Castro DG, Bridge JA, Wallace A, Deignan JL, Hing S, Butler R, Verghese E, Latham GJ, Hamoudi RA (2015) Variation in pre-PCR processing of FFPE samples leads to discrepancies in BRAF and EGFR mutation detection: a diagnostic RING trial. J Clin Pathol 68(2):111\u2013118. doi: 10.1136\/jclinpath-2014-202644","journal-title":"J Clin Pathol"},{"issue":"3","key":"2025_CR34","doi-asserted-by":"publisher","first-page":"236","DOI":"10.4132\/jptm.2015.03.16","volume":"49","author":"SE Choi","year":"2015","unstructured":"Choi SE, Hong SW, Yoon SO (2015) Proposal of an appropriate decalcification method of bone marrow biopsy specimens in the era of expanding genetic molecular study. J Pathol Transl Med 49(3):236\u2013242. doi: 10.4132\/jptm.2015.03.16","journal-title":"J Pathol Transl Med"},{"key":"2025_CR35","doi-asserted-by":"publisher","unstructured":"Pengelly RJ, Gibson J, Andreoletti G, Collins A, Mattocks CJ, Ennis S (2013) A SNP profiling panel for sample tracking in whole-exome sequencing studies. Genome Med 5(9):89. doi: 10.1186\/gm492 . eCollection 2013. Erratum in: Genome Med. 2015;7(1):44.","DOI":"10.1186\/gm492"},{"issue":"3","key":"2025_CR36","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1101\/gr.8.3.175","volume":"8","author":"B Ewing","year":"1998","unstructured":"Ewing B, Hillier L, Wendl MC, Green P (1998) Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res 8(3):175\u2013185","journal-title":"Genome Res"},{"issue":"3","key":"2025_CR37","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1101\/gr.8.3.186","volume":"8","author":"B Ewing","year":"1998","unstructured":"Ewing B, Green P (1998) Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res 8(3):186\u2013194","journal-title":"Genome Res"},{"issue":"3","key":"2025_CR38","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/gb-2014-15-3-r53","volume":"15","author":"CA Brownstein","year":"2014","unstructured":"Brownstein CA, Beggs AH, Homer N et al (2014) An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY challenge. Genome Biol 15(3):R53. doi: 10.1186\/gb-2014-15-3-r53","journal-title":"Genome Biol"},{"key":"2025_CR39","doi-asserted-by":"crossref","unstructured":"Cornish A, Guda C (2015) A comparison of variant calling pipelines using genome in a bottle as a reference. BioMed Research International 456479 10.1155\/2015\/456479.","DOI":"10.1155\/2015\/456479"},{"key":"2025_CR40","doi-asserted-by":"publisher","first-page":"17875","DOI":"10.1038\/srep17875","volume":"5","author":"S Hwang","year":"2015","unstructured":"Hwang S, Kim E, Lee I, Marcotte EM (2015) Systematic comparison of variant calling pipelines using gold standard personal exome variants. Scientific reports 5:17875. doi: 10.1038\/srep17875","journal-title":"Scientific reports"},{"issue":"5","key":"2025_CR41","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJMc052564","volume":"354","author":"A Marchetti","year":"2006","unstructured":"Marchetti A, Felicioni L, Buttitta F (2006) Assessing EGFR mutations. N Engl J Med 354(5):526\u2013528 author reply 526-8","journal-title":"N Engl J Med"},{"key":"2025_CR42","doi-asserted-by":"crossref","first-page":"546","DOI":"10.18632\/oncotarget.503","volume":"5","author":"H Do","year":"2012","unstructured":"Do H, Dobrovic A (2012) Dramatic reduction of sequence artefacts from DNA isolated from formalin-fixed cancer biopsies by treatment with uracil-DNA glycosylase. Oncotarget 5:546\u2013558","journal-title":"Oncotarget"},{"key":"2025_CR43","doi-asserted-by":"publisher","unstructured":"Quail MA, Smith M, Coupland P, Otto TD, Harris SR, Connor TR, Bertoni A, Swerdlow HP, Gu Y (2012) A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics 13. doi: 10.1186\/1471-2164-13-341","DOI":"10.1186\/1471-2164-13-341"},{"key":"2025_CR44","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/1471-2164-15-516","volume":"15","author":"ZX Yeo","year":"2014","unstructured":"Yeo ZX, Wong JC, Rozen SG1, Lee AS (2014) Evaluation and optimisation of indel detection workflows for ion torrent sequencing of the BRCA1 and BRCA2 genes. BMC Genomics 15:516. doi: 10.1186\/1471-2164-15-516","journal-title":"BMC Genomics"},{"issue":"5","key":"2025_CR45","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL, ACMG Laboratory Quality Assurance Committee (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405\u2013424. doi: 10.1038\/gim.2015.30","journal-title":"Genet Med"},{"issue":"11","key":"2025_CR46","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/humu.20880","volume":"29","author":"SE Plon","year":"2008","unstructured":"Plon SE, Eccles DM, Easton D, Foulkes WD, Genuardi M, Greenblatt MS, Hogervorst FB, Hoogerbrugge N, Spurdle AB, Tavtigian SV (2008) Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test results. Hum Mutat 29(11):1282\u20131291. doi: 10.1002\/humu.20880","journal-title":"Hum Mutat"},{"key":"2025_CR47","doi-asserted-by":"publisher","unstructured":"Meric-Bernstam F, Johnson A, Holla V, Bailey AM, Brusco L, Chen K, Routbort M, Patel KP, Zeng J, Kopetz S, Davies MA, Piha-Paul SA, Hong DS, Eterovic AK, Tsimberidou AM, Broaddus R, Bernstam EV, Shaw KR, Mendelsohn J, Mills GB (2015) A decision support framework for genomically informed investigational cancer therapy. J Natl Cancer Inst 107(7). doi: 10.1093\/jnci\/djv098 Print 2015 Jul","DOI":"10.1093\/jnci\/djv098"},{"key":"2025_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12907-015-0004-6","volume":"15","author":"G Ellison","year":"2015","unstructured":"Ellison G, Huang S2, Carr H3, Wallace A2, Ahdesmaki M4, Bhaskar S2, Mills J (2015) A reliable method for the detection of BRCA1 and BRCA2 mutations in fixed tumour tissue utilising multiplex PCR-based targeted next generation sequencing. BMC Clin Pathol 15:5. doi: 10.1186\/s12907-015-0004-6 eCollection 2015","journal-title":"BMC Clin Pathol"},{"key":"2025_CR49","unstructured":"Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases http:\/\/www.fda.gov\/downloads\/MedicalDevices\/DeviceRegulationandGuidance\/GuidanceDocuments\/UCM509838.pdf (accessed July 21, 2016)."}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-016-2025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00428-016-2025-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-016-2025-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T23:47:39Z","timestamp":1498348059000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00428-016-2025-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,27]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["2025"],"URL":"https:\/\/doi.org\/10.1007\/s00428-016-2025-7","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,27]]}}}